AzTrials
AzTrials

Stress (Psychology)NCT07174544

Mobile Self-Management Program for Stress Reduction in Young Adults

A study testing Mobile Self-Management Program integrated with Positive Psychology and Behavioral Activation in people with Stress (Psychology), run by The Catholic University of Korea at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if a mobile self-management program that combines Positive Psychology (PP) and Behavioral Activation (BA) helps reduce stress in young adults in South Korea. It will also examine how the program affects depression, anxiety, and resilience. Read more about this study

Who is it for?
Ages 19 to 34 yearsHealthy volunteers can take part
Conditions the study is for
Stress (Psychology)
What is being tested?
Mobile Self-Management Program integrated with Positive Psychology and Behavioral Activation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
211 participants
Where
1 siteSouth Korea
Study dates
1 Sep 2023to 30 Aug 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 34 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 19-34 years at the time of participation
  • Proficiency in using digital devices
  • Use of an Android-based smartphone or tablet
  • Score of ≥14 on the Perceived Stress Scale-10 (PSS-10)
  • Provision of informed consent for random assignment

Who cannot join

  • Score <14 on the Perceived Stress Scale-10 (PSS-10)
  • Declines random assignment

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • College of Nursing, The Catholic University of Korea

    Seoul, Seoul, 06591

Other trials in South Korea

About this study

Official title: Mobile Self-Management Program Integrating Positive Psychology and Behavioral Activation for Stress Reduction in Young Adults: A Community-Based Randomized Controlled Trial

The goal of this clinical trial is to learn if a mobile self-management program that combines Positive Psychology (PP) and Behavioral Activation (BA) helps reduce stress in young adults in South Korea. It will also examine how the program affects depression, anxiety, and resilience.

The main questions it aims to answer are:

Read more

Does the program lower stress levels in young adults with high stress?

Does the program improve other aspects of mental health, such as depression, anxiety, and resilience?

Researchers will compare the mobile program to a wait-list control group to see if the program works to improve stress management.

Participants will:

Be randomly assigned to either the program group or a wait-list control group

Use the mobile program for 4 weeks with guided activities, followed by 4 weeks of self-directed use

Complete surveys at the start, week 2, week 4, and week 8 about their stress, depression, anxiety, and resilience

Being tested
Mobile Self-Management Program integrated with Positive Psychology and Behavioral Activation
Keywords
Stress, Resilience, Self-Management, Positive Psychology, Mobile Applications, Young Adult

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobile Self-Management Program integrated with Positive Psychology and Behavioral ActivationBehavioural

    The mobile self-management program consisted of a 4-week guided intervention phase followed by a 4-week self-directed period to encourage continued use. The guided phase was organized around weekly objectives: (1) experiencing positive affect, (2) identifying personal strengths, (3) applying strengths in daily life, and (4) planning a positive future. Program activities included emotional check-ins, gratitude journaling, mindfulness practice, positive behavioral tasks, and goal setting. During the self-directed phase (Weeks 5-8), participants selected from 10 recommended activities tailored to their strengths, promoting sustained engagement and self-management. The program integrated Positive Psychology and Behavioral Activation strategies to reduce stress, enhance resilience, and foster positive behavioral change.

Study groups in NCT07174544
Study groupRoleWhat they receive
Intervention groupExperimentalParticipants receive a mobile self-management intervention that integrates Positive Psychology and Behavioral Activation. The program includes 4 weeks of guided sessions followed by 4 weeks of self-directed use.
Receives: Behavioral: Mobile Self-Management Program integrated with Positive Psychology and Behavioral Activation
Wait-list ControlNo interventionParticipants do not receive the intervention during the first 8 weeks but are offered access to the program after the study period.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stress at Week 8

    Stress was measured using the Korean version of the Perceived Stress Scale - 10 items (PSS-10). The total score ranges from 0 to 40, with higher scores indicating greater perceived stress. Although the scale does not provide a standardized cut-off, prior studies have used a score of 14 or higher to define moderate-to-high levels of stress, and this threshold was applied in the present study.

    Measured: Week 8

Secondary outcomes (15)
  1. Stress at Baseline

    Stress was measured using the Korean version of the Perceived Stress Scale - 10 items (PSS-10). The total score ranges from 0 to 40, with higher scores indicating greater perceived stress. Although the scale does not provide a standardized cut-off, prior studies have used a score of 14 or higher to define moderate-to-high levels of stress, and this threshold was applied in the present study.

    Measured: Baseline

  2. Stress at Week 2

    Stress was measured using the Korean version of the Perceived Stress Scale - 10 items (PSS-10). The total score ranges from 0 to 40, with higher scores indicating greater perceived stress. Although the scale does not provide a standardized cut-off, prior studies have used a score of 14 or higher to define moderate-to-high levels of stress, and this threshold was applied in the present study.

    Measured: Week 2

  3. Stress at Week 4

    Stress was measured using the Korean version of the Perceived Stress Scale - 10 items (PSS-10). The total score ranges from 0 to 40, with higher scores indicating greater perceived stress. Although the scale does not provide a standardized cut-off, prior studies have used a score of 14 or higher to define moderate-to-high levels of stress, and this threshold was applied in the present study.

    Measured: Week 4

  4. Depression (PHQ-9) at Baseline

    Depression was assessed using the Korean version of the Patient Health Questionnaire-9 items (PHQ-9). The PHQ-9 consists of nine items rated on a 4-point Likert scale (0 = not at all to 3 = nearly every day), assessing symptom frequency over the past two weeks. The total score ranges from 0 to 27, with higher scores indicating more severe depression.

    Measured: Baseline

  5. Depression (PHQ-9) at Week 2

    Depression was assessed using the Korean version of the Patient Health Questionnaire-9 items (PHQ-9). The PHQ-9 consists of nine items rated on a 4-point Likert scale (0 = not at all to 3 = nearly every day), assessing symptom frequency over the past two weeks. The total score ranges from 0 to 27, with higher scores indicating more severe depression.

    Measured: Week 2

  6. Depression (PHQ-9) at Week 4

    Depression was assessed using the Korean version of the Patient Health Questionnaire-9 items (PHQ-9). The PHQ-9 consists of nine items rated on a 4-point Likert scale (0 = not at all to 3 = nearly every day), assessing symptom frequency over the past two weeks. The total score ranges from 0 to 27, with higher scores indicating more severe depression.

    Measured: Week 4

  7. Depression (PHQ-9) at Week 8

    Depression was assessed using the Korean version of the Patient Health Questionnaire-9 items (PHQ-9). The PHQ-9 consists of nine items rated on a 4-point Likert scale (0 = not at all to 3 = nearly every day), assessing symptom frequency over the past two weeks. The total score ranges from 0 to 27, with higher scores indicating more severe depression.

    Measured: Week 8

  8. Anxiety (GAD-7) at Baseline

    Anxiety was measured using the Korean version of the Generalized Anxiety Disorder-7 items (GAD-7). The GAD-7 consists of seven items rated on a 4-point Likert scale (0 = not at all to 3 = nearly every day), assessing symptom frequency over the past two weeks. The total score ranges from 0 to 21, with higher scores indicating more severe anxiety.

    Measured: Baseline

  9. Anxiety (GAD-7) at Week 2

    Anxiety was measured using the Korean version of the Generalized Anxiety Disorder-7 items (GAD-7). The GAD-7 consists of seven items rated on a 4-point Likert scale (0 = not at all to 3 = nearly every day), assessing symptom frequency over the past two weeks. The total score ranges from 0 to 21, with higher scores indicating more severe anxiety.

    Measured: Week 2

  10. Anxiety (GAD-7) at Week 4

    Anxiety was measured using the Korean version of the Generalized Anxiety Disorder-7 items (GAD-7). The GAD-7 consists of seven items rated on a 4-point Likert scale (0 = not at all to 3 = nearly every day), assessing symptom frequency over the past two weeks. The total score ranges from 0 to 21, with higher scores indicating more severe anxiety.

    Measured: Week 4

  11. Anxiety (GAD-7) at Week 8

    Anxiety was measured using the Korean version of the Generalized Anxiety Disorder-7 items (GAD-7). The GAD-7 consists of seven items rated on a 4-point Likert scale (0 = not at all to 3 = nearly every day), assessing symptom frequency over the past two weeks. The total score ranges from 0 to 21, with higher scores indicating more severe anxiety.

    Measured: Week 8

  12. Resilience ( BRS) at Baseline

    Resilience was assessed using the Korean version of the Brief Resilience Scale (BRS). The BRS consists of six items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Total scores range from 6 to 30, with higher scores indicating greater resilience.

    Measured: Baseline

  13. Resilience (BRS) at Week 2

    Resilience was assessed using the Korean version of the Brief Resilience Scale (BRS). The BRS consists of six items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Total scores range from 6 to 30, with higher scores indicating greater resilience.

    Measured: Week 2

  14. Resilience (BRS) at Week 4

    Resilience was assessed using the Korean version of the Brief Resilience Scale (BRS). The BRS consists of six items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Total scores range from 6 to 30, with higher scores indicating greater resilience.

    Measured: Week 4

  15. Resilience (BRS) at Week 8

    Resilience was assessed using the Korean version of the Brief Resilience Scale (BRS). The BRS consists of six items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Total scores range from 6 to 30, with higher scores indicating greater resilience.

    Measured: Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2025
  2. Study start1 Sep 2023
  3. Primary completion31 Dec 2024
  4. Study completion30 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
211 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07174544
Sponsor's protocol ID
MC23FNSI0059
Other IDs
NRF-2022R1A2C1011568
Status last verified
Dec 2025
First submitted
11 Sep 2025
Last updated
8 Jan 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The study's informed consent form restricts use of data to this research only. Therefore, IPD will not be shared with other researchers.

Publications

  • Oh D, Choi HS, Mohr DC, Na H. Effects of a mobile-based self-management program on mental health in young adults: a randomized controlled trial. Front Public Health. 2026 Jun 17;14:1830292. doi: 10.3389/fpubh.2026.1830292. eCollection 2026.

    PubMed 42388766

Questions about this trial

What is this clinical trial studying?

A study testing Mobile Self-Management Program integrated with Positive Psychology and Behavioral Activation in people with Stress (Psychology), run by The Catholic University of Korea at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 8 Jan 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stress at Week 8 (time frame: Week 8). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07174544, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in